Who owns Editas Medicine, Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of EDIT from SEC Form 13F filings across 214 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 214 institutions disclosed 119.3M shares of Editas Medicine, Inc. worth $386.3M — about 100% of shares outstanding; the largest disclosed holder is TCG Crossover Management, LLC. Source: SEC Form 13F filings, parsed by EvidInvest.
214
13F holders
$386.3M
value, 2026 filers
100%
of shares outstanding (119.3M sh)
38
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30 · % of fund = share of the manager's own book · % of co. = share of EDIT's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | TCG Crossover Management, LLCNEW | 11.1M | $36.0M | 0.9% | 9.3% | new |
| 2 | BlackRock, Inc. | 10.6M | $34.3M | 0.0% | 8.9% | +14.3% |
| 3 | Commodore Capital LPNEW | 8.9M | $28.8M | 1.7% | 7.5% | new |
| 4 | ADAR1 Capital Management, LLCNEW | 8.9M | $28.8M | 1.3% | 7.5% | new |
| 5 | RA CAPITAL MANAGEMENT, L.P.NEW | 8.9M | $28.8M | 0.3% | 7.5% | new |
| 6 | VANGUARD CAPITAL MANAGEMENT LLC | 6.1M | $19.9M | 0.0% | 5.1% | +46.1% |
| 7 | Paradigm Biocapital Advisors LPNEW | 5.6M | $18.1M | 0.3% | 4.7% | new |
| 8 | Opaleye Management Inc. | 3.9M | $12.5M | 1.1% | 3.2% | +100.4% |
| 9 | VANGUARD PORTFOLIO MANAGEMENT LLC | 3.6M | $11.7M | 0.0% | 3% | +14.3% |
| 10 | Woodline Partners LPNEW | 3.6M | $11.5M | 0.0% | 3% | new |
| 11 | Vivo Capital, LLCNEW | 3.6M | $11.5M | 1.1% | 3% | new |
| 12 | GordonMD Global Investments LPNEW | 3.1M | $10.1M | 4.9% | 2.6% | new |
| 13 | GOLDMAN SACHS GROUP INC | 2.6M | $8.5M | 0.0% | 2.2% | +368.0% |
| 14 | GEODE CAPITAL MANAGEMENT, LLC | 2.6M | $8.3M | 0.0% | 2.2% | +11.1% |
| 15 | RENAISSANCE TECHNOLOGIES LLC | 2.5M | $8.0M | 0.0% | 2.1% | -37.8% |
| 16 | Logos Global Management LPNEW | 2.2M | $7.2M | 0.3% | 1.9% | new |
| 17 | STATE STREET CORP | 2.2M | $7.1M | 0.0% | 1.8% | +5.6% |
| 18 | MARSHALL WACE, LLP | 2.0M | $6.6M | 0.0% | 1.7% | +868.7% |
| 19 | D. E. Shaw & Co., Inc. | 1.9M | $6.2M | 0.0% | 1.6% | -2.2% |
| 20 | JPMORGAN CHASE & CO | 1.9M | $6.0M | 0.0% | 1.6% | -4.4% |
| 21 | AQR CAPITAL MANAGEMENT LLC | 1.6M | $5.1M | 0.0% | 1.3% | +14.7% |
| 22 | TWO SIGMA INVESTMENTS, LP | 1.3M | $4.3M | 0.0% | 1.1% | -13.9% |
| 23 | Seven Fleet Capital Management LPNEW | 1.3M | $4.3M | 0.7% | 1.1% | new |
| 24 | RAYMOND JAMES FINANCIAL INC | 1.3M | $4.3M | 0.0% | 1.1% | +1.9% |
| 25 | ACADIAN ASSET MANAGEMENT LLC | 1.0M | $3.4M | 0.0% | 0.9% | -28.7% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.